Glycogenosis type I and diabetes mellitus: a common mechanism for renal dysfunction?

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Medical Hypotheses

• Publication date

  2002-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0306-9877(02)00199-8PMID 12160694
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Glucose-6-phosphate: A key compound in glycogenosis I and favism leading to hyper- or hypolipidaemia

  2005cited by this paper
• Aldose reductase and the role of the polyol pathway in diabetic nephropathy.

  2000cited by this paper
• The role of lipids in renal disease: future challenges.

  2000cited by this paper
• Diabetic nephropathy.

  1999cited by this paper
• Recent advances in statins and the kidney.

  1999cited by this paper
• Glomerular hyperfiltration in experimental diabetes mellitus: potential role of tubular reabsorption.

  1999cited by this paper
• Tubuloglomerular feedback: new concepts and developments.

  1998cited by this paper
• Protein kinase C activation and the development of diabetic complications.

  1998cited by this paper
• The role of angiotensin II in diabetic nephropathy: emphasis on nonhemodynamic mechanisms.

  1997cited by this paper
• Localization of cyclooxygenase-1 and -2 in adult and fetal human kidney: implication for renal function.

  1997cited by this paper
• Neutralization of TGF-β by Anti-TGF-β Antibody Attenuates Kidney Hypertrophy and the Enhanced Extracellular Matrix Gene Expression in STZ-Induced Diabetic Mice

  1996cited by this paper
• Effects of lipids on the pathogenesis of progressive renal failure: role of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in the prevention of glomerulosclerosis.

  1996cited by this paper
• Hyperglycemia and Diabetic Kidney Disease: The Case for Transforming Growth Factor–β as a Key Mediator

  1995cited by this paper
• Glomerular and tubular function in glycogen storage disease

  1995cited by this paper
• Hyperlipidaemia does not impair vascular endothelial function in glycogen storage disease type 1a.

  1994cited by this paper
• Activation of Protein Kinase C in Glomerular Cells in Diabetes: Mechanisms and Potential Links to the Pathogenesis of Diabetic Glomerulopathy

  1994cited by this paper
• Role for Protein Kinase C in the Mediation of Increased Fibronectin Accumulation by Mesangial Cells Grown in High-Glucose Medium

  1993cited by this paper
• Cytokines in kidney disease: the role of transforming growth factor-beta.

  1993cited by this paper
• Glomerular hyperfiltration in insulin-dependent diabetes mellitus is correlated with enhanced growth hormone secretion.

  1993cited by this paper
• Renal proximal and distal tubular function is attenuated in diabetes mellitus type 1 as determined by the renal excretion of α1-microglobulin and Tamm-Horsfall protein

  1993cited by this paper
• Angiotensin II-induced hypertrophy of cultured murine proximal tubular cells is mediated by endogenous transforming growth factor-beta.

  1993cited by this paper
• Role of cofactors in protein kinase C activation.

  1992cited by this paper
• Elevated glucose stimulates TGF-beta gene expression and bioactivity in proximal tubule.

  1992cited by this paper
• Endogenous angiotensin concentrations in specific intrarenal fluid compartments of the rat.

  1990cited by this paper
• Increase in Diacylglycerol Mass in Isolated Glomeruli by Glucose From De Novo Synthesis of Glycerolipids

  1990cited by this paper
• Angiotensin II: a powerful controller of sodium transport in the early proximal tubule.

  1990cited by this paper
• Amelioration of proximal renal tubular dysfunction in type I glycogen storage disease with dietary therapy.

  1990cited by this paper
• Hyperfiltration and renal disease in glycogen storage disease, type I.

  1989cited by this paper
• Protein kinase C is activated in glomeruli from streptozotocin diabetic rats. Possible mediation by glucose.

  1989cited by this paper
• Renal disease in type I glycogen storage disease.

  1988cited by this paper
• Renal glomerular and tubular abnormalities in glycogen storage disease type I.

  1988cited by this paper
• Sequential alterations in glomerular prostaglandin and thromboxane synthesis in diabetic rats: relationship to the hyperfiltration of early diabetes.

  1987cited by this paper
• The role of lipids in progressive glomerular disease.

  1987cited by this paper
• Early glomerular hyperfiltration in insulin-dependent diabetics and late nephropathy.

  1986cited by this paper
• Regulatory Aspects of Cholesterol Metabolism in Cells with Different Degrees of Replication

  1986cited by this paper
• Proximal Renal Tubular Acidosis in a Child with Type 1 Glycogen Storage Disease

  1986cited by this paper
• Predicting diabetic nephropathy in insulin-dependent patients.

  1984cited by this paper
• Concentration-dependent sodium chloride transport as the signal in feedback control of glomerular filtration rate.

  1982cited by this paper
• Effect of glycine and glucagon on glomerular filtration and renal metabolic rates.

  1977cited by this paper
• GLYCOGEN STORAGE DISEASE.

  1964cited by this paper

• Congenital nephrotic syndrome in a newborn with glycogen storage disease and Wilms tumor 1 (WT1) mutation

  2026cites this paper
• Kidney involvement in glycogen storage disease type I: Current knowledge and key challenges.

  2025cites this paper
• Glycogen storage disease type I: Genetic etiology, clinical manifestations, and conventional and gene therapies

  2023cites this paper
• Effects of fructose from apple and honey on serum uric acid in young Chinese: Randomized crossover trials.

  2022cites this paper
• The natural history of glycogen storage disease type Ib in England: A multisite survey

  2021cites this paper
• General Discussion and Future Perspectives

  2019cites this paper
• Master role of glucose-6-phosphate in cell signaling and consequences of its deregulation in the liver and kidneys

  2019cites this paper
• Advanced Glycation Endproducts and the Absence of Premature Atherosclerosis in Glycogen Storage Disease 1 a

  2019cites this paper
• Polycystic kidney features of the renal pathology in glycogen storage disease type I: possible evolution to renal neoplasia

  2018cites this paper
• COMPLEX FORMATION EQUILIBRIA OF COPPER(II), METFORMIN AND D-(+)MANNOSE OR D-(+)GLUCOSE IN METHANOL

  2017cites this paper
• Progressive development of renal cysts in glycogen storage disease type I.

  2016cites this paper
• [Renal involvement in glycogen storage disease type 1: Practical issues].

  2015cites this paper
• Renal manifestations of metabolic disorders in children

  2015cites this paper
• Lessons from new mouse models of glycogen storage disease type 1a in relation to the time course and organ specificity of the disease

  2015cites this paper
• Diagnosis of hepatic glycogenosis in poorly controlled type 1 diabetes mellitus.

  2014cites this paper
• Targeted deletion of kidney glucose-6 phosphatase leads to nephropathy.

  2014cites this paper
• Diagnosis and management of glycogen storage disease type I: a practice guideline of the American College of Medical Genetics and Genomics

  2014cites this paper
• Multiple roles of glucose-6-phosphatases in pathophysiology: state of the art and future trends.

  2013cites this paper
• Glycogen storage disease type 1 and diabetes: learning by comparing and contrasting the two disorders.

  2013cites this paper
• Sugar, Uric Acid, and the Etiology of Diabetes and Obesity

  2013cites this paper
• Glycogen Storage Disease type 1a – a secondary cause for hyperlipidemia: report of five cases

  2013cites this paper
• In search of proof-of-concept: gene therapy for glycogen storage disease type Ia

  2012cites this paper
• Hepatorenal correction in murine glycogen storage disease type I with a double-stranded adeno-associated virus vector.

  2011cites this paper
• Oxidative stress mediates nephropathy in type Ia glycogen storage disease

  2010cites this paper
• Emerging therapies for glycogen storage disease type I.

  2009cites this paper
• Renal Manifestations of Metabolic Disorders

  2009cites this paper
• Renal function in glycogen storage disease type I, natural course, and renopreservative effects of ACE inhibition.

  2009influential citation
• Advanced Glycation Endproducts and the Absence of Premature Atherosclerosis in Glycogen Storage Disease 1a

  2007cites this paper
• Advanced glycation end products and the absence of premature atherosclerosis in glycogen storage disease Ia

  2007cites this paper
• Efficacy of ACE‐inhibitor therapy on renal disease in glycogen storage disease type 1: a multicentre retrospective study

  2005cites this paper
• Glycogen storage disease type I: clinical, biochemical and genetic aspects, and implications for treatment and follow-up

  2003cites this paper